Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

patientcentricity

- PMLiVE

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Medscape Education

- PMLiVE

US FDA launches ultra-rare diseases framework

The draft guidance specifically discusses genome editing and RNA-based therapies

- PMLiVE

N4 Pharma appoints David Solomon as CEO

The company is to be renamed Thalia Therapeutics to reflect its strategic transition

- PMLiVE

Why stigma is a launch risk in rare disease – and what commercial leaders can do about it

Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.

Havas Life London

- PMLiVE

New report identifies stigma as a structural barrier in rare disease

The study finds that healthcare settings are a leading source of stigma for people living with rare conditions

- PMLiVE

Patient-centricity in rare disease: accelerating the path to treatment

By Chris Moore

- PMLiVE

GenAI in healthcare: why privacy and literacy matter more than the tech

By Dimitri Challouma

Involvement of children and young people in research and publication development

From ‘why’ to ‘how’: patient partnership across age groups in research and publications

By Sarah Mohamad

Amiculum

- PMLiVE

From Static to Strategic: The 2026 Playbook for Longitudinal Pharma Interaction

Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 Engagement Toolkit—a deep dive into the immersive, longitudinal strategies and newly...

Impetus Digital

- PMLiVE

Novo Nordisk and Vivtex partner in deal worth up to $2.1bn

The companies aim to develop next-generation oral medicines for obesity and diabetes

- PMLiVE

AI-enabled, human-interpreted: the future of pharma marketing insights is precision intelligence

By Abigail Stuart

- PMLiVE

It’s time for an end to pharma exceptionalism

By Mark Ralphs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links